Showing results (1451-1460 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|October 20, 2023
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future PrioritiesJohn A Ligon, Sneha Ramakrishna, Francesco Ceppi, et al.
Transplantation and Cellular Therapy|October 11, 2023
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic LeukemiaLena E Winestone, Deepa Bhojwani, Sara Ghorashian, et al.
Transplantation and Cellular Therapy|October 7, 2023
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Tania Jain, et al.
Transplantation and Cellular Therapy|October 3, 2023
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell TransplantationKarthik Nath, Kristen Peterson, Samantha Brown, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Transplantation and Cellular Therapy|September 20, 2023
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic AnemiaYasushi Onishi, Takehiko Mori, Hirohito Yamazaki, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
Transplantation and Cellular Therapy|September 25, 2023
Haploidentical Cord Blood Transplantation with 8 mg/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg/kg Antithymocyte Globulin in the Treatment of Acute LeukemiaFangfang Yuan, Gangping Li, Minghui Li, et al.
Transplantation and Cellular Therapy|July 4, 2023
Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood TransplantationSumiko Fujita, Maki Monna-Oiwa, Seiko Kato, et al.
Transplantation and Cellular Therapy|July 22, 2023
Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell TransplantationFumiya Wada, Yasuyuki Arai, Tomoyasu Jo, et al.
Pageof 183